Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H1 2017
|
IDRA |
|
Phase 2 Results |
Oncology |
Orphan Drug |
|
H2 2016
|
PTLA |
|
NDA Submission |
Other |
Fast Track |
|
H2 2016
|
AXON |
|
Phase 2 Results |
Neurology |
None |
|
H2 2017
|
OTIC |
|
Phase 3 Results |
Neurology |
Fast Track |
|
H2 2016
|
IRWD |
|
Phase 1b Results |
Cardiovascular |
None |
|
Q4 2017
|
ARNA |
|
Phase 2 Results |
Other |
None |
|
Q1 2017
|
CLBS |
|
Phase 2 Results |
Endocrine |
Orphan Drug |
|
H2 2016
|
LXRX |
|
Phase 3 Results |
Endocrine |
None |
|
H2 2016
|
RARE |
|
Phase 2 Results |
Oncology |
None |
|
H2 2017
|
GWPH |
|
Phase 3 Results |
Oncology |
Orphan Drug |
|